<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03136367</url>
  </required_header>
  <id_info>
    <org_study_id>D17063</org_study_id>
    <nct_id>NCT03136367</nct_id>
  </id_info>
  <brief_title>What Matters Most: Choosing the Right Breast Cancer Surgery for You</brief_title>
  <official_title>Comparative Effectiveness of Encounter Decision Aids for Early-Stage Breast Cancer Across Socioeconomic Strata</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      What Matters Most is a study that aims to determine how best to help women of lower&#xD;
      socioeconomic status make high-quality decisions about early stage breast cancer treatments.&#xD;
      What Matters Most will be comparing two decision aids used in the clinic visit to usual care&#xD;
      (what normally happens in the clinic). The first decision aid (Option Grid) presents&#xD;
      evidence-based information about lumpectomy and mastectomy in a tabular format using text&#xD;
      only. The second decision aid (Picture Option Grid) presents evidence-based information about&#xD;
      lumpectomy and mastectomy using pictures, pictographs and simplified text. What Matters Most&#xD;
      aims to show that the interventions can reduce disparities in decision-making and treatment&#xD;
      choice between women of high and low SES.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and Significance&#xD;
&#xD;
      Breast cancer is the most commonly diagnosed malignancy in women. Despite improvements in&#xD;
      survival, women of low socioeconomic status (SES) diagnosed with early stage breast cancer:&#xD;
&#xD;
        -  Continue to experience poorer doctor-patient communication, lower satisfaction with&#xD;
           surgery and decision making, and higher decision regret compared to women of higher SES;&#xD;
&#xD;
        -  Often play a passive role in decision making;&#xD;
&#xD;
        -  Are less likely to undergo breast-conserving surgery (BCS);&#xD;
&#xD;
        -  Are less likely to receive optimal care.&#xD;
&#xD;
      Those differences are disparities that predominantly affect women of low SES with early stage&#xD;
      breast cancer, irrespective of race or ethnicity. For early stage breast cancer, low SES is a&#xD;
      stronger predictor of poorer outcomes, treatment received and death, than race or ethnicity.&#xD;
      The investigators define low SES as a lower income, lower educational attainment, and&#xD;
      uninsured or state-insured status&#xD;
&#xD;
      Although BCS is the recommended treatment for early stage breast cancer (stages I to IIIA),&#xD;
      research confirms equivalent survival between mastectomy and BCS. Both options are offered&#xD;
      yet have distinct harms and benefits, valued differently by patients. The patient and&#xD;
      stakeholder partners involved in this study have emphasized the critical importance of&#xD;
      supporting women in making high quality breast cancer surgery decisions (good knowledge and&#xD;
      alignment between the patient's choice, values and priorities) irrespective of SES and health&#xD;
      literacy. Yet, research shows that women of low SES are not usually involved in an informed,&#xD;
      patient-centered dialogue about surgery choice. There is no evidence that women of low SES&#xD;
      have distinct preferences that explain a lower uptake of BCS and limited engagement in&#xD;
      decision making. Further, communication strategies are not typically adapted to women of low&#xD;
      SES and low health literacy. Most decision aids for breast cancer have been designed for&#xD;
      highly literate audiences, with poor accessibility and readability. Simpler, shorter decision&#xD;
      aids delivered in the clinical encounter (encounter decision aids) may be more beneficial to&#xD;
      underserved patients, and could reduce disparities. It is critical to determine how to&#xD;
      effectively support women of low SES in making informed breast cancer surgery choices.&#xD;
&#xD;
      Study Aims&#xD;
&#xD;
      First, the investigators will assess the comparative effectiveness of two effective encounter&#xD;
      decision aids (Option Grid and Picture Option Grid) against usual care on decision quality&#xD;
      (primary outcome), shared decision making, treatment choice and other secondary outcomes&#xD;
      across socioeconomic strata (Aim 1). Second, the investigators aim to explore the effect of&#xD;
      the Picture Option Grid on disparities in decision making (decision quality, knowledge, and&#xD;
      shared decision making), treatment choice, as well as mediation and moderation effects (Aim&#xD;
      2). Third, in order to maximize the implementation potential, the investigators will explore&#xD;
      strategies that promote the encounter decision aids' sustained use and dissemination using a&#xD;
      theoretical implementation model (Aim 3).&#xD;
&#xD;
      Study Description&#xD;
&#xD;
      The investigators will conduct a three-arm, multi-site randomized controlled superiority&#xD;
      trial with stratification by SES (Aims 1 and 2) and randomization at the clinician level. One&#xD;
      thousand, one hundred patients (half of higher SES and half of lower SES) will be recruited&#xD;
      from five large cancer centers. In preparation for the trial (Year 01), the investigators&#xD;
      will conduct semi-structured interviews with women of low SES who have completed treatment&#xD;
      for early stage breast cancer to adapt the &quot;What Matters Most to You&quot; subscale of the&#xD;
      Decision Quality Instrument (DQI) for women of low SES. Lastly, the investigators will use&#xD;
      interviews, field-notes, and observations to explore strategies that promote the&#xD;
      interventions' sustained use and dissemination using the Normalization Process Theory (Aim&#xD;
      3). Community-Based Participatory Research will be used throughout the trial (with continuous&#xD;
      patient and stakeholder involvement).&#xD;
&#xD;
      Women 18 years and older with a confirmed diagnosis of early stage breast cancer (I to IIIA)&#xD;
      from both higher and lower SES will be included in the trial, provided they have a basic&#xD;
      command of English, Spanish, or Mandarin. About 367 patients will be recruited per arm.&#xD;
&#xD;
      Both interventions have been developed, tested, and shown to be effective. The Option Grid&#xD;
      (intervention 1) is a one-page evidence-based summary of available options presented in a&#xD;
      tabular format, listing the trade-offs that patients normally consider when making breast&#xD;
      cancer surgery decisions. The Picture Option Grid (intervention 2) uses the same evidence and&#xD;
      tabular layout, but it is tailored to women of lower SES and low health literacy and includes&#xD;
      simple text and images. Because decision aids are not routinely available in real world&#xD;
      settings, usual care is a coherent and legitimate comparator. It will include the provision&#xD;
      of usual information resources about breast cancer but will exclude the provision of other&#xD;
      decision aids.&#xD;
&#xD;
      Secondary outcome measures will include treatment choice, the validated 3-item CollaboRATE&#xD;
      measure of shared decision-making (SDM), Chew's validated one-item health literacy screening&#xD;
      question, PROMIS, an 8-item validated anxiety short form, EQ-5D-5L, a validated, standardized&#xD;
      6-item quality of life measure, and four items from COST, a validated financial toxicity&#xD;
      measure. Participants will also be asked to estimate their out-of-pocket expenses over the&#xD;
      past month. All measures will be available in English, Spanish, and Mandarin. Observer&#xD;
      OPTION5 will be used to rate the level of shared decision making in the clinical encounter.&#xD;
&#xD;
      A regression framework (logistic regression, linear regression, mixed effect regression&#xD;
      models, generalized estimating equations) and mediation analyses will be used in the&#xD;
      analysis. The investigators will also use multiple informants analysis to measure and examine&#xD;
      SES and multiple imputation to manage missing data. Heterogeneity of treatment effects&#xD;
      analyses for SES, age, ethnicity, race, literacy, language, and study site will be performed.&#xD;
      The investigators will also use the recordings of surgical consultations to analyze the&#xD;
      conversations about costs and treatment recommendations made by providers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 18, 2017</start_date>
  <completion_date type="Actual">May 31, 2019</completion_date>
  <primary_completion_date type="Actual">May 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Three-arm randomized controlled superiority trial with stratification by SES and randomization at the clinician level. Patient enrollment will occur at five cancer centers in the United States. Patients will be enrolled in one of the three arms based on the clinician they are seeing as a part of their care.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Data analysts will be blinded to the clinician randomization.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Decision Quality: Knowledge Subscale</measure>
    <time_frame>Immediately before the index surgical consultation visit, immediately after the index surgical consultation visit and at one week post-surgery</time_frame>
    <description>Change in decision quality, measured using the validated 16-item Decision Quality Worksheet for Breast Cancer Surgery. Decision quality is measured through three constructs: knowledge, decision process, and concordance. Knowledge is five questions that results in a score from 0 to 5 with higher numbers indicating higher knowledge. Decision process is a measure how much shared decision making process occurred, based on patient-report. It is a seven-item scale with higher numbers indicating higher shared decision process. For the concordance score, patients rated their goals and concerns on an 11-point importance scale from 0 (not important at all) to 10 (extremely important). They also indicated which surgery they intended to have at T2. A concordance summary score (0-100%) indicated the percentage of patients who received a treatment that matched their stated preference.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Decision Quality: Decison Process Subscale</measure>
    <time_frame>Immediately after the index surgical consultation visit and at one week post-surgery</time_frame>
    <description>Change in decision quality, measured using the validated 16-item Decision Quality Worksheet for Breast Cancer Surgery. Decision quality is measured through three constructs: knowledge, decision process, and concordance. Knowledge is five questions that results in a score from 0 to 5 with higher numbers indicating higher knowledge. Decision process is a measure how much shared decision making process occurred, based on patient-report. It is a seven-item scale from 0 to 7 with higher numbers indicating higher shared decision process. For the concordance score, patients rated their goals and concerns on an 11-point importance scale from 0 (not important at all) to 10 (extremely important). They also indicated which surgery they intended to have at T2. A concordance score indicated the percentage of patients who received a treatment that matched their stated preference.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Decision Quality: Concordance Subscale</measure>
    <time_frame>Immediately after the index surgical consultation visit and at one week post-surgery</time_frame>
    <description>Change in decision quality, measured using the validated 16-item Decision Quality Worksheet for Breast Cancer Surgery. Decision quality is measured through three constructs: knowledge, decision process, and concordance. Knowledge is five questions that results in a score from 0 to 5 with higher numbers indicating higher knowledge. Decision process is a measure how much shared decision making process occurred, based on patient-report. It is a seven-item scale with higher numbers indicating higher shared decision process. For the concordance score, patients rated their goals and concerns on an 11-point importance scale from 0 (not important at all) to 10 (extremely important). They also indicated which surgery they intended to have at T2. A concordance summary score (0-100%) indicated the percentage of patients who received a treatment that matched their stated preference at T2 (lumpectomy vs mastectomy).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Chose Lumpectomy or Mastectomy as Their Treatment Choice</measure>
    <time_frame>1 week post-surgery</time_frame>
    <description>Treatment choice, or which surgical or treatment option the patient chose, mastectomy or lumpectomy (breast conserving surgery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life</measure>
    <time_frame>Immediately before the index surgical consultation visit and at 12 weeks post-surgery</time_frame>
    <description>Quality of life reported by the patient measured using the validated 6-item EQ-5D-5L measure. We used the available resources from EuroQol to convert EQ-5D-5L states into an index value, using the EQ-5D-5L crosswalk value sets. Index values ranged from full health (1) and to no health (-0.109), according to the US crosswalk value set.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>Immediately before the index surgical consultation visit, immediately after the index surgical consultation visit, at 1 week post-surgery, and at 12 weeks post-surgery</time_frame>
    <description>Patient-reported anxiety, measured using the validated 8-item PROMIS anxiety short form. Each question was coded from one to five. Total scores were obtained by scoring the raw score of each item answered. The lowest possible raw score was 8; the highest possible raw score was 40 with higher numbers indicating higher anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shared Decision-making (Self-reported)</measure>
    <time_frame>Immediately after the index surgical consultation visit</time_frame>
    <description>Self-reported shared decision-making about breast cancer surgical options measured using the validated 3-item CollaboRATE measure. Each item was rated on a scale from 0 to 9 with a possible score range from 0 to 27. We dichotomized this measure using the top score approach, grouping participants scoring 9 on all three items versus all others.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shared Decision-making (Observed)</measure>
    <time_frame>During the index surgical consultation visit</time_frame>
    <description>Shared decision-making observed during the surgical consultation, measured using the validated observer-rated OPTION5. The five items on the measure ask raters to score the consultation on how much the clinician: 1) confirms that alternatives exist, 2) reassures that they will support the patient to become informed, 3) gives information or checks understanding about the options, 4) makes an effort to elicit the patient's preferences, and 5) integrates the patient's elicited preferences. Each of the five items is scored from zero to four for a summary score ranging from zero to 20 and a scaled score ranging from zero to 100. Higher numbers indicate more shared decision making was observed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decision Regret</measure>
    <time_frame>At 1 week post-surgery, 12 weeks post-surgery, and 1 year post-surgery</time_frame>
    <description>Patient-reported feelings of decision regret, measured using the validated 5-item decision regret scale. Items 2 and 4 were reverse coded so a higher number indicated more regret. Scores were then converted to a 0-100 scale by subtracting 1 from each item then multiply by 25. To obtain a final score, the items were summed and averaged. A score of 0 meant no regret and a score of 100 meant high regret.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Integration of Health Care Delivery</measure>
    <time_frame>Immediately before the index surgical consultation visit and at 12 weeks post-surgery</time_frame>
    <description>Patient-reported measure of integration of healthcare delivery, measured using IntegRATE, a 4-item scale. IntegRATE sum scores are determined by summing each participant's scores across the 4 items (range 0-12). A higher score indicates higher integration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exploration of Strategies That Promote the Interventions' Sustained Use and Dissemination</measure>
    <time_frame>12 weeks post-surgery (patients) or after trial participation ended (surgeons)</time_frame>
    <description>Semi-structured interviews with clinic stakeholders and patients 12 weeks post-surgery, field notes, and clinic observations to explore strategies that promote the interventions' sustained use and dissemination</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">571</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Arm 1: Option Grid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2: Picture Option Grid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3: Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In the usual care arm, surgeons provided their standard information about breast cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Option Grid</intervention_name>
    <description>The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
    <arm_group_label>Arm 1: Option Grid</arm_group_label>
    <other_name>Option Grid for Breast Cancer Surgery</other_name>
    <other_name>Breast cancer: surgical options</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Picture Option Grid</intervention_name>
    <description>The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
    <arm_group_label>Arm 2: Picture Option Grid</arm_group_label>
    <other_name>Early-stage breast cancer: What's right for me?</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Assigned female at birth;&#xD;
&#xD;
          -  18 years and older;&#xD;
&#xD;
          -  Confirmed diagnosis (via biopsy) of early stage breast cancer (stages I-IIIA);&#xD;
&#xD;
          -  Eligible for both breast-conserving surgery and mastectomy based on medical records&#xD;
             and clinician's opinion before surgery;&#xD;
&#xD;
          -  Spoken English, Spanish, or Mandarin Chinese.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Transgender men and women;&#xD;
&#xD;
          -  Women who have undergone prophylactic mastectomy;&#xD;
&#xD;
          -  Women with visual impairment;&#xD;
&#xD;
          -  Women with a diagnosis of severe mental illness or severe dementia;&#xD;
&#xD;
          -  Women with inflammatory breast carcinoma.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>In order to be in this trial, participants must have been assigned female at birth. Transgender men will also be excluded as their treatment course would be managed on a case-by-case basis.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Ann Durand, MSc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dartmouth-Hitchcock Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University in St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bellevue Hospital Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://mattersmoststudy.com</url>
    <description>Study Website</description>
  </link>
  <reference>
    <citation>Lee CN, Wetschler MH, Chang Y, Belkora JK, Moy B, Partridge A, Sepucha KR. Measuring decision quality: psychometric evaluation of a new instrument for breast cancer chemotherapy. BMC Med Inform Decis Mak. 2014 Aug 20;14:73. doi: 10.1186/1472-6947-14-73.</citation>
    <PMID>25142035</PMID>
  </reference>
  <reference>
    <citation>Chew LD, Griffin JM, Partin MR, Noorbaloochi S, Grill JP, Snyder A, Bradley KA, Nugent SM, Baines AD, Vanryn M. Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med. 2008 May;23(5):561-6. doi: 10.1007/s11606-008-0520-5. Epub 2008 Mar 12.</citation>
    <PMID>18335281</PMID>
  </reference>
  <reference>
    <citation>Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.</citation>
    <PMID>21479777</PMID>
  </reference>
  <reference>
    <citation>Barr PJ, Thompson R, Walsh T, Grande SW, Ozanne EM, Elwyn G. The psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process. J Med Internet Res. 2014 Jan 3;16(1):e2. doi: 10.2196/jmir.3085. Erratum in: J Med Internet Res. 2015;17(2):e32. J Med Internet Res. 2015;17(2):e32.</citation>
    <PMID>24389354</PMID>
  </reference>
  <reference>
    <citation>Barr PJ, O'Malley AJ, Tsulukidze M, Gionfriddo MR, Montori V, Elwyn G. The psychometric properties of Observer OPTION(5), an observer measure of shared decision making. Patient Educ Couns. 2015 Aug;98(8):970-6. doi: 10.1016/j.pec.2015.04.010. Epub 2015 Apr 29.</citation>
    <PMID>25956069</PMID>
  </reference>
  <reference>
    <citation>Elwyn G, Barr PJ, Grande SW, Thompson R, Walsh T, Ozanne EM. Developing CollaboRATE: a fast and frugal patient-reported measure of shared decision making in clinical encounters. Patient Educ Couns. 2013 Oct;93(1):102-7. doi: 10.1016/j.pec.2013.05.009. Epub 2013 Jun 12.</citation>
    <PMID>23768763</PMID>
  </reference>
  <reference>
    <citation>Brehaut JC, O'Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, Feldman-Stewart D. Validation of a decision regret scale. Med Decis Making. 2003 Jul-Aug;23(4):281-92.</citation>
    <PMID>12926578</PMID>
  </reference>
  <reference>
    <citation>Elwyn G, Thompson R, John R, Grande SW. Developing IntegRATE: a fast and frugal patient-reported measure of integration in health care delivery. Int J Integr Care. 2015 Mar 27;15:e008. eCollection 2015 Jan-Mar.</citation>
    <PMID>26034467</PMID>
  </reference>
  <reference>
    <citation>Pickard AS, De Leon MC, Kohlmann T, Cella D, Rosenbloom S. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care. 2007 Mar;45(3):259-63.</citation>
    <PMID>17304084</PMID>
  </reference>
  <reference>
    <citation>Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D; PROMIS Cooperative Group. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMISÂ®): depression, anxiety, and anger. Assessment. 2011 Sep;18(3):263-83. doi: 10.1177/1073191111411667. Epub 2011 Jun 21.</citation>
    <PMID>21697139</PMID>
  </reference>
  <reference>
    <citation>Sepucha KR, Belkora JK, Chang Y, Cosenza C, Levin CA, Moy B, Partridge A, Lee CN. Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery. BMC Med Inform Decis Mak. 2012 Jun 8;12:51. doi: 10.1186/1472-6947-12-51.</citation>
    <PMID>22681763</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>April 25, 2017</study_first_submitted>
  <study_first_submitted_qc>April 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2017</study_first_posted>
  <results_first_submitted>August 3, 2020</results_first_submitted>
  <results_first_submitted_qc>December 8, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 5, 2021</results_first_posted>
  <last_update_submitted>December 8, 2020</last_update_submitted>
  <last_update_submitted_qc>December 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dartmouth-Hitchcock Medical Center</investigator_affiliation>
    <investigator_full_name>Marie-Anne Durand</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>encounter decision aids</keyword>
  <keyword>shared decision making</keyword>
  <keyword>socioeconomic status</keyword>
  <keyword>disparities</keyword>
  <keyword>decision quality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 28, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/67/NCT03136367/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between September 2017 and February 2019, we screened 2,057 of a target 2,200 patients; 1,031 patients remained eligible. We approached 885 eligible patients, of which 622 (76.6%) consented. Sixteen surgeons saw 571 of 622 consented patients.</recruitment_details>
      <pre_assignment_details>Sixteen surgeons saw 571 of 622 consented patients. The imbalanced allocation to arms was due to differences in the number of patients seen by each surgeon, or changes in their role or attendance. Of 440 patients who consented to recording, we collected 311 (70.7%) usable recordings.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm 1: Option Grid</title>
          <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
        </group>
        <group group_id="P2">
          <title>Arm 2: Picture Option Grid</title>
          <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
        </group>
        <group group_id="P3">
          <title>Arm 3: Usual Care</title>
          <description>In the usual care arm, surgeons provided their standard information about breast cancer.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>T1 Consultation</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="248"/>
                <participants group_id="P3" count="257"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="64">received the intervention</participants>
                <participants group_id="P2" count="241"/>
                <participants group_id="P3" count="256"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>discontinued mistakenly included</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discontinued other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>T2 Post-consultation</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="241"/>
                <participants group_id="P3" count="256"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="61"/>
                <participants group_id="P2" count="235"/>
                <participants group_id="P3" count="225"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="31"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>discontinued mistakenly included</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discontinued other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discontinued transferred care</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discontinued lost contact</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>T3 1 Week After Surgery</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="61"/>
                <participants group_id="P2" count="235"/>
                <participants group_id="P3" count="225"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="203"/>
                <participants group_id="P3" count="194"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="31"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Discontinued mistakenly included</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discontinued transferred care</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>other discontinued</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discontinued lost contact</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>T4 12 Weeks After Surgery</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="203"/>
                <participants group_id="P3" count="194"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="198"/>
                <participants group_id="P3" count="185"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>discontinued lost contact</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>discontinued transferred care</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>discontinued mistakenly included</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>T5 1 Year After Surgery</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="198"/>
                <participants group_id="P3" count="185"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="62"/>
                <participants group_id="P3" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="136"/>
                <participants group_id="P3" count="129"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>discontinued mistakenly included</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discontinued lost contact</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>study ended before due</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="103"/>
                <participants group_id="P3" count="110"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>logistical issues prevented contact</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>622 participants consented to take part but 6 participants withdrew consent immediately before or during baseline, leaving 616 participant with baseline information.</population>
      <group_list>
        <group group_id="B1">
          <title>Arm 1: Option Grid</title>
          <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
        </group>
        <group group_id="B2">
          <title>Arm 2: Picture Option Grid</title>
          <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
        </group>
        <group group_id="B3">
          <title>Arm 3: Usual Care</title>
          <description>In the usual care arm, surgeons provided their standard information about breast cancer</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="69"/>
            <count group_id="B2" value="276"/>
            <count group_id="B3" value="271"/>
            <count group_id="B4" value="616"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.1" spread="11.5"/>
                    <measurement group_id="B2" value="58.9" spread="13.0"/>
                    <measurement group_id="B3" value="60.4" spread="12.2"/>
                    <measurement group_id="B4" value="59.7" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="276"/>
                    <measurement group_id="B3" value="271"/>
                    <measurement group_id="B4" value="616"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="40"/>
                    <measurement group_id="B4" value="96"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="218"/>
                    <measurement group_id="B3" value="208"/>
                    <measurement group_id="B4" value="472"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Decision Quality: Knowledge Subscale</title>
        <description>Change in decision quality, measured using the validated 16-item Decision Quality Worksheet for Breast Cancer Surgery. Decision quality is measured through three constructs: knowledge, decision process, and concordance. Knowledge is five questions that results in a score from 0 to 5 with higher numbers indicating higher knowledge. Decision process is a measure how much shared decision making process occurred, based on patient-report. It is a seven-item scale with higher numbers indicating higher shared decision process. For the concordance score, patients rated their goals and concerns on an 11-point importance scale from 0 (not important at all) to 10 (extremely important). They also indicated which surgery they intended to have at T2. A concordance summary score (0-100%) indicated the percentage of patients who received a treatment that matched their stated preference.</description>
        <time_frame>Immediately before the index surgical consultation visit, immediately after the index surgical consultation visit and at one week post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Option Grid</title>
            <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Picture Option Grid</title>
            <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Usual Care</title>
            <description>In the usual care arm, surgeons provided their standard information about breast cancer.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Decision Quality: Knowledge Subscale</title>
          <description>Change in decision quality, measured using the validated 16-item Decision Quality Worksheet for Breast Cancer Surgery. Decision quality is measured through three constructs: knowledge, decision process, and concordance. Knowledge is five questions that results in a score from 0 to 5 with higher numbers indicating higher knowledge. Decision process is a measure how much shared decision making process occurred, based on patient-report. It is a seven-item scale with higher numbers indicating higher shared decision process. For the concordance score, patients rated their goals and concerns on an 11-point importance scale from 0 (not important at all) to 10 (extremely important). They also indicated which surgery they intended to have at T2. A concordance summary score (0-100%) indicated the percentage of patients who received a treatment that matched their stated preference.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="248"/>
                <count group_id="O3" value="257"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Immediately before the index surgical consultation visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.83" spread="1.29"/>
                    <measurement group_id="O2" value="2.95" spread="1.22"/>
                    <measurement group_id="O3" value="2.77" spread="1.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Immediately after the index surgical consultation visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.82" spread="1.13"/>
                    <measurement group_id="O2" value="2.90" spread="1.07"/>
                    <measurement group_id="O3" value="2.74" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>One week post-surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.00" spread="1.11"/>
                    <measurement group_id="O2" value="2.88" spread="1.05"/>
                    <measurement group_id="O3" value="2.87" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.045</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.20</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.82</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Decision Quality: Decison Process Subscale</title>
        <description>Change in decision quality, measured using the validated 16-item Decision Quality Worksheet for Breast Cancer Surgery. Decision quality is measured through three constructs: knowledge, decision process, and concordance. Knowledge is five questions that results in a score from 0 to 5 with higher numbers indicating higher knowledge. Decision process is a measure how much shared decision making process occurred, based on patient-report. It is a seven-item scale from 0 to 7 with higher numbers indicating higher shared decision process. For the concordance score, patients rated their goals and concerns on an 11-point importance scale from 0 (not important at all) to 10 (extremely important). They also indicated which surgery they intended to have at T2. A concordance score indicated the percentage of patients who received a treatment that matched their stated preference.</description>
        <time_frame>Immediately after the index surgical consultation visit and at one week post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Option Grid</title>
            <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Picture Option Grid</title>
            <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Usual Care</title>
            <description>In the usual care arm, surgeons provided their standard information about breast cancer.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Decision Quality: Decison Process Subscale</title>
          <description>Change in decision quality, measured using the validated 16-item Decision Quality Worksheet for Breast Cancer Surgery. Decision quality is measured through three constructs: knowledge, decision process, and concordance. Knowledge is five questions that results in a score from 0 to 5 with higher numbers indicating higher knowledge. Decision process is a measure how much shared decision making process occurred, based on patient-report. It is a seven-item scale from 0 to 7 with higher numbers indicating higher shared decision process. For the concordance score, patients rated their goals and concerns on an 11-point importance scale from 0 (not important at all) to 10 (extremely important). They also indicated which surgery they intended to have at T2. A concordance score indicated the percentage of patients who received a treatment that matched their stated preference.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="248"/>
                <count group_id="O3" value="257"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Immediately after the index surgical consultation visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.66" spread="1.24"/>
                    <measurement group_id="O2" value="5.47" spread="1.58"/>
                    <measurement group_id="O3" value="4.57" spread="2.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>One week post-surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.67" spread="1.26"/>
                    <measurement group_id="O2" value="5.02" spread="1.73"/>
                    <measurement group_id="O3" value="4.64" spread="1.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.048</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.015</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.43</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Decision Quality: Concordance Subscale</title>
        <description>Change in decision quality, measured using the validated 16-item Decision Quality Worksheet for Breast Cancer Surgery. Decision quality is measured through three constructs: knowledge, decision process, and concordance. Knowledge is five questions that results in a score from 0 to 5 with higher numbers indicating higher knowledge. Decision process is a measure how much shared decision making process occurred, based on patient-report. It is a seven-item scale with higher numbers indicating higher shared decision process. For the concordance score, patients rated their goals and concerns on an 11-point importance scale from 0 (not important at all) to 10 (extremely important). They also indicated which surgery they intended to have at T2. A concordance summary score (0-100%) indicated the percentage of patients who received a treatment that matched their stated preference at T2 (lumpectomy vs mastectomy).</description>
        <time_frame>Immediately after the index surgical consultation visit and at one week post-surgery</time_frame>
        <population>Only participants who remained in the trial through when they had their surgery were analyzed for this outcome in order to assess the match between treatment intent and treatment received.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Option Grid</title>
            <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Picture Option Grid</title>
            <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Usual Care</title>
            <description>In the usual care arm, surgeons provided their standard information about breast cancer.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Decision Quality: Concordance Subscale</title>
          <description>Change in decision quality, measured using the validated 16-item Decision Quality Worksheet for Breast Cancer Surgery. Decision quality is measured through three constructs: knowledge, decision process, and concordance. Knowledge is five questions that results in a score from 0 to 5 with higher numbers indicating higher knowledge. Decision process is a measure how much shared decision making process occurred, based on patient-report. It is a seven-item scale with higher numbers indicating higher shared decision process. For the concordance score, patients rated their goals and concerns on an 11-point importance scale from 0 (not important at all) to 10 (extremely important). They also indicated which surgery they intended to have at T2. A concordance summary score (0-100%) indicated the percentage of patients who received a treatment that matched their stated preference at T2 (lumpectomy vs mastectomy).</description>
          <population>Only participants who remained in the trial through when they had their surgery were analyzed for this outcome in order to assess the match between treatment intent and treatment received.</population>
          <units>percentage with treatment match</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="168"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.3"/>
                    <measurement group_id="O2" value="92.9"/>
                    <measurement group_id="O3" value="95.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.46</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.34</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.165</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Chose Lumpectomy or Mastectomy as Their Treatment Choice</title>
        <description>Treatment choice, or which surgical or treatment option the patient chose, mastectomy or lumpectomy (breast conserving surgery)</description>
        <time_frame>1 week post-surgery</time_frame>
        <population>The number of participants analyzed for treatment choice was different from other outcome measures as it is based on the number of participants for whom treatment choice data was available.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Option Grid</title>
            <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Picture Option Grid</title>
            <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Usual Care</title>
            <description>In the usual care arm, surgeons provided their standard information about breast cancer</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Chose Lumpectomy or Mastectomy as Their Treatment Choice</title>
          <description>Treatment choice, or which surgical or treatment option the patient chose, mastectomy or lumpectomy (breast conserving surgery)</description>
          <population>The number of participants analyzed for treatment choice was different from other outcome measures as it is based on the number of participants for whom treatment choice data was available.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="200"/>
                <count group_id="O3" value="192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>lumpectomy</title>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="161"/>
                    <measurement group_id="O3" value="146"/>
                  </measurement_list>
                </category>
                <category>
                  <title>mastectomy</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Quality of Life</title>
        <description>Quality of life reported by the patient measured using the validated 6-item EQ-5D-5L measure. We used the available resources from EuroQol to convert EQ-5D-5L states into an index value, using the EQ-5D-5L crosswalk value sets. Index values ranged from full health (1) and to no health (-0.109), according to the US crosswalk value set.</description>
        <time_frame>Immediately before the index surgical consultation visit and at 12 weeks post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Option Grid</title>
            <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Picture Option Grid</title>
            <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Usual Care</title>
            <description>In the usual care arm, surgeons provided their standard information about breast cancer.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Quality of Life</title>
          <description>Quality of life reported by the patient measured using the validated 6-item EQ-5D-5L measure. We used the available resources from EuroQol to convert EQ-5D-5L states into an index value, using the EQ-5D-5L crosswalk value sets. Index values ranged from full health (1) and to no health (-0.109), according to the US crosswalk value set.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="248"/>
                <count group_id="O3" value="257"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Immediately before the index surgical consultation visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.83" spread="0.13"/>
                    <measurement group_id="O2" value="0.82" spread="0.13"/>
                    <measurement group_id="O3" value="0.82" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks post-surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.82" spread="0.10"/>
                    <measurement group_id="O2" value="0.85" spread="0.13"/>
                    <measurement group_id="O3" value="0.82" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.25</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.89</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.54</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Anxiety</title>
        <description>Patient-reported anxiety, measured using the validated 8-item PROMIS anxiety short form. Each question was coded from one to five. Total scores were obtained by scoring the raw score of each item answered. The lowest possible raw score was 8; the highest possible raw score was 40 with higher numbers indicating higher anxiety.</description>
        <time_frame>Immediately before the index surgical consultation visit, immediately after the index surgical consultation visit, at 1 week post-surgery, and at 12 weeks post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Option Grid</title>
            <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Picture Option Grid</title>
            <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Usual Care</title>
            <description>In the usual care arm, surgeons provided their standard information about breast cancer</description>
          </group>
        </group_list>
        <measure>
          <title>Anxiety</title>
          <description>Patient-reported anxiety, measured using the validated 8-item PROMIS anxiety short form. Each question was coded from one to five. Total scores were obtained by scoring the raw score of each item answered. The lowest possible raw score was 8; the highest possible raw score was 40 with higher numbers indicating higher anxiety.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="248"/>
                <count group_id="O3" value="257"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Immediately before the index surgical consultation visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.8" spread="6.8"/>
                    <measurement group_id="O2" value="20.2" spread="7.4"/>
                    <measurement group_id="O3" value="20.7" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>immediately after the index surgical consultation visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.0" spread="6.7"/>
                    <measurement group_id="O2" value="20.4" spread="8.1"/>
                    <measurement group_id="O3" value="20.6" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 week post-surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.2" spread="7.3"/>
                    <measurement group_id="O2" value="17.0" spread="7.1"/>
                    <measurement group_id="O3" value="17.1" spread="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks post-surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.1" spread="6.5"/>
                    <measurement group_id="O2" value="13.0" spread="5.6"/>
                    <measurement group_id="O3" value="14.9" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.72</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.41</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>McNemar</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.28</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Shared Decision-making (Self-reported)</title>
        <description>Self-reported shared decision-making about breast cancer surgical options measured using the validated 3-item CollaboRATE measure. Each item was rated on a scale from 0 to 9 with a possible score range from 0 to 27. We dichotomized this measure using the top score approach, grouping participants scoring 9 on all three items versus all others.</description>
        <time_frame>Immediately after the index surgical consultation visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Option Grid</title>
            <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Picture Option Grid</title>
            <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Usual Care</title>
            <description>In the usual care arm, surgeons provided their standard information about breast cancer</description>
          </group>
        </group_list>
        <measure>
          <title>Shared Decision-making (Self-reported)</title>
          <description>Self-reported shared decision-making about breast cancer surgical options measured using the validated 3-item CollaboRATE measure. Each item was rated on a scale from 0 to 9 with a possible score range from 0 to 27. We dichotomized this measure using the top score approach, grouping participants scoring 9 on all three items versus all others.</description>
          <units>percentage of patients with a top score</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="248"/>
                <count group_id="O3" value="257"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73" lower_limit="48" upper_limit="99"/>
                    <measurement group_id="O2" value="76" lower_limit="55" upper_limit="97"/>
                    <measurement group_id="O3" value="58" lower_limit="52" upper_limit="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.12</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.78</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Shared Decision-making (Observed)</title>
        <description>Shared decision-making observed during the surgical consultation, measured using the validated observer-rated OPTION5. The five items on the measure ask raters to score the consultation on how much the clinician: 1) confirms that alternatives exist, 2) reassures that they will support the patient to become informed, 3) gives information or checks understanding about the options, 4) makes an effort to elicit the patient's preferences, and 5) integrates the patient's elicited preferences. Each of the five items is scored from zero to four for a summary score ranging from zero to 20 and a scaled score ranging from zero to 100. Higher numbers indicate more shared decision making was observed.</description>
        <time_frame>During the index surgical consultation visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Option Grid</title>
            <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Picture Option Grid</title>
            <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Usual Care</title>
            <description>In the usual care arm, surgeons provided their standard information about breast cancer</description>
          </group>
        </group_list>
        <measure>
          <title>Shared Decision-making (Observed)</title>
          <description>Shared decision-making observed during the surgical consultation, measured using the validated observer-rated OPTION5. The five items on the measure ask raters to score the consultation on how much the clinician: 1) confirms that alternatives exist, 2) reassures that they will support the patient to become informed, 3) gives information or checks understanding about the options, 4) makes an effort to elicit the patient's preferences, and 5) integrates the patient's elicited preferences. Each of the five items is scored from zero to four for a summary score ranging from zero to 20 and a scaled score ranging from zero to 100. Higher numbers indicate more shared decision making was observed.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="143"/>
                <count group_id="O3" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.92" lower_limit="42.51" upper_limit="95.16"/>
                    <measurement group_id="O2" value="65.72" lower_limit="41.84" upper_limit="89.45"/>
                    <measurement group_id="O3" value="41.02" lower_limit="36.20" upper_limit="45.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Decision Regret</title>
        <description>Patient-reported feelings of decision regret, measured using the validated 5-item decision regret scale. Items 2 and 4 were reverse coded so a higher number indicated more regret. Scores were then converted to a 0-100 scale by subtracting 1 from each item then multiply by 25. To obtain a final score, the items were summed and averaged. A score of 0 meant no regret and a score of 100 meant high regret.</description>
        <time_frame>At 1 week post-surgery, 12 weeks post-surgery, and 1 year post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Option Grid</title>
            <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Picture Option Grid</title>
            <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Usual Care</title>
            <description>In the usual care arm, surgeons provided their standard information about breast cancer</description>
          </group>
        </group_list>
        <measure>
          <title>Decision Regret</title>
          <description>Patient-reported feelings of decision regret, measured using the validated 5-item decision regret scale. Items 2 and 4 were reverse coded so a higher number indicated more regret. Scores were then converted to a 0-100 scale by subtracting 1 from each item then multiply by 25. To obtain a final score, the items were summed and averaged. A score of 0 meant no regret and a score of 100 meant high regret.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="248"/>
                <count group_id="O3" value="257"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 week post-surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.9" spread="13.9"/>
                    <measurement group_id="O2" value="8.1" spread="12.3"/>
                    <measurement group_id="O3" value="12.9" spread="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks post-surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.0" spread="15.9"/>
                    <measurement group_id="O2" value="7.6" spread="12.3"/>
                    <measurement group_id="O3" value="10.8" spread="16.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year post-surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" spread="14.1"/>
                    <measurement group_id="O2" value="6.0" spread="10.3"/>
                    <measurement group_id="O3" value="7.6" spread="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.06</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.65</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.36</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Integration of Health Care Delivery</title>
        <description>Patient-reported measure of integration of healthcare delivery, measured using IntegRATE, a 4-item scale. IntegRATE sum scores are determined by summing each participant's scores across the 4 items (range 0-12). A higher score indicates higher integration.</description>
        <time_frame>Immediately before the index surgical consultation visit and at 12 weeks post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Option Grid</title>
            <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Picture Option Grid</title>
            <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Usual Care</title>
            <description>In the usual care arm, surgeons provided their standard information about breast cancer</description>
          </group>
        </group_list>
        <measure>
          <title>Integration of Health Care Delivery</title>
          <description>Patient-reported measure of integration of healthcare delivery, measured using IntegRATE, a 4-item scale. IntegRATE sum scores are determined by summing each participant's scores across the 4 items (range 0-12). A higher score indicates higher integration.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="248"/>
                <count group_id="O3" value="257"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Immediately before the index surgical consultation visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" spread="1.8"/>
                    <measurement group_id="O2" value="10.2" spread="2.0"/>
                    <measurement group_id="O3" value="10.3" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks post-surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.9" spread="1.1"/>
                    <measurement group_id="O2" value="10.8" spread="1.5"/>
                    <measurement group_id="O3" value="10.6" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.11</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.037</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.28</p_value>
            <p_value_desc>Adjusted for repeated within-patient measurements.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects linear regression that accounted for clinician and site clustering and was adjusted for surgeon and patient characteristics.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Exploration of Strategies That Promote the Interventions' Sustained Use and Dissemination</title>
        <description>Semi-structured interviews with clinic stakeholders and patients 12 weeks post-surgery, field notes, and clinic observations to explore strategies that promote the interventions' sustained use and dissemination</description>
        <time_frame>12 weeks post-surgery (patients) or after trial participation ended (surgeons)</time_frame>
        <population>The results are reported in two groups: patients and all surgeons. The data collection method used was semi-structured interview (using a purposive sampling technique). This was a qualitative exploration of the data. We did not interview all participants but only purposively selected 42 participants in the intervention arms. Some results in this section only apply to patients (e.g., helped with decision) and some only apply to surgeons (e.g., would recommend to other health professionals).</population>
        <group_list>
          <group group_id="O1">
            <title>Patients in Intervention Arms</title>
            <description>Patients in this group received either the Option Grid or Picture Option Grid as a part of their care. Only patients in the intervention arms were interviewed for this outcome measure.</description>
          </group>
          <group group_id="O2">
            <title>Surgeons Involved in the Trial</title>
            <description>This group included all surgeons who participated in the trial. All surgeons were interviewed for this outcome measure.</description>
          </group>
        </group_list>
        <measure>
          <title>Exploration of Strategies That Promote the Interventions' Sustained Use and Dissemination</title>
          <description>Semi-structured interviews with clinic stakeholders and patients 12 weeks post-surgery, field notes, and clinic observations to explore strategies that promote the interventions' sustained use and dissemination</description>
          <population>The results are reported in two groups: patients and all surgeons. The data collection method used was semi-structured interview (using a purposive sampling technique). This was a qualitative exploration of the data. We did not interview all participants but only purposively selected 42 participants in the intervention arms. Some results in this section only apply to patients (e.g., helped with decision) and some only apply to surgeons (e.g., would recommend to other health professionals).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Aid affected treatment decision</title>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Aid was part of normal routine</title>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Want paper-based materials</title>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Thought receiving aid from the surgeon is best</title>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Open to receiving the aid in virtual formats</title>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Open to receiving/giving aid before appointment</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Aid would be helpful for lower literacy patients</title>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">This category/result only applies to surgeons.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Recommended other health professionals use the aid</title>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">This category/result only applies to surgeons.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Were able to integrate the aid into their routine</title>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">This category/result only applies to surgeons.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All trial surgeons</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Aid affected treatment decision</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to patients.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Aid was part of normal routine</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to patients.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Want paper-based materials</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to patients.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Thought receiving aid from the surgeon is best</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to patients.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Open to receiving the aid in virtual formats</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to patients.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Open to receiving/giving aid before appointment</title>
                  <measurement_list>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Aid would be helpful for lower literacy patients</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to surgeons in the intervention arms.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Recommended other health professionals use the aid</title>
                  <measurement_list>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Were able to integrate the aid into their routine</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to surgeons in the intervention arms.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intervention surgeons</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Aid affected treatment decision</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to patients.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Aid was part of normal routine</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to patients.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Want paper-based materials</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to patients.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Thought receiving aid from the surgeon is best</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to patients.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Open to receiving the aid in virtual formats</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to patients.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Open to receiving/giving aid before appointment</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to patients or the entire surgeon group analysis.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Aid would be helpful for lower literacy patients</title>
                  <measurement_list>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Recommended other health professionals use the aid</title>
                  <measurement_list>
                    <measurement group_id="O2" value="NA">This category/result only applies to patients or the entire surgeon group analysis.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Were able to integrate the aid into their routine</title>
                  <measurement_list>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Arm 1: Option Grid</title>
          <description>Patients in this arm will receive the Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Option Grid: The Option Grid(TM) encounter decision aid for early stage breast cancer surgery is a one-page, evidence-based summary of available options presented in a tabular format.</description>
        </group>
        <group group_id="E2">
          <title>Arm 2: Picture Option Grid</title>
          <description>Patients in this arm will receive the Picture Option Grid for breast cancer surgery, an encounter decision aid, when they first meet with the breast surgeon to discuss their surgical options for breast cancer treatment.&#xD;
Picture Option Grid: The Picture Option Grid was derived from the Option Grid for early stage breast cancer. It uses the same evidence and integrates images and simpler text, thus exploiting pictorial superiority. The Picture Option Grid has been specifically designed for women of lower SES and low health literacy.</description>
        </group>
        <group group_id="E3">
          <title>Arm 3: Usual Care</title>
          <description>In the usual care arm, surgeons provided their standard information about breast cancer.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="248"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="257"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="248"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="248"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="257"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Marie-Anne Durand</name_or_title>
      <organization>Dartmouth College</organization>
      <phone>603-667-8601</phone>
      <email>marie-anne.durand@dartmouth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

